3 completed, 1 not yet recruiting. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 3, Not yet recruiting 1 |
Follow chiglitazar: new trials by email Literature Review of chiglitazar trials Research Report on chiglitazar
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Food Effect and Multiple-Dose Study of Chiglitazar/Metformin Extended-Release Tablets Chiglitazar/Metformin extended-release tablets under fasting conditions, Chiglitazar/Metformin extended-release tablets after a high-fat meal, multiple-dose of Chiglitazar/Metformin extended-release tablets - T2DM (Type 2 Diabetes Mellitus) | Phase 1 | Not yet recruiting | Chipscreen Biosciences, Ltd. | 28 | 2026-10-08 | 2026-04-06 |
| Drug-Drug Interaction Study of Chiglitazar in Healthy Subjects. Chiglitazar, Empagliflozin, Atorvastatin - T2DM | Phase 1 | Completed | Chipscreen Biosciences, Ltd. | 48 | 2023-02-17 | 2023-06-15 |
| Pharmacokinetics of Chiglitazar in Subjects With Hepatic Impairment and Normal Hepatic Function Chiglitazar - Hepatic Impairment | Phase 1 | Completed | Chipscreen Biosciences, Ltd. | 24 | 2022-12-03 | 2024-05-28 |
| Pharmacokinetics of Chiglitazar in Subjects With Renal Impairment and Normal Renal Function Chiglitazar - Renal Impairment | Phase 1 | Completed | Chipscreen Biosciences, Ltd. | 24 | 2022-11-20 | 2024-05-28 |
Diabetes Mellitus, Type 2 (1) · Renal Insufficiency (1)
Chipscreen Biosciences, Ltd. (4)
China (3)
LiYan Miao (2) · Hongrong Xu (1)